The FDA July 31 issued a safety communication urging users of Hospira Inc.’s Symbiq Infusion System — a computerized infusion pump used in hospitals, nursing homes and outpatient care centers — to discontinue use of the device due to “cybersecurity vulnerabilities.” The infusion pump “can be accessed remotely through a hospital’s network,” the agency said, allowing unauthori... Read More